360° Coverage : Paid COPD Clinical Trial Now Enrolling at Avail Clinical...

1 Updates

Paid COPD Clinical Trial Now Enrolling at Avail Clinical Research Near Orlando, Florida; Accepting M/F Patients with COPD Age 40+

Sep 29 2013, 11:48am CDT | by PR.com

Avail is conducting a 24-week study to evaluate the effect of a once-daily experimental inhalation therapy on arterial stiffness compared to a placebo and another drug in subjects with Chronic Obstructive Pulmonary Disease (COPD).

DeLand, FL, September 29, 2013 --(PR.com)-- To see if you qualify for this COPD Clinical Trial in Florida, visit Avail Clinical Research on the web (http://www.availclinical.com) or contact us...

Filed under: news

YouTube Videos

 
 
 

43 weeks ago

Paid COPD Clinical Trial Now Enrolling at Avail Clinical Research Near Orlando, Florida; Accepting M/F Patients with COPD Age 40+

Sep 29 2013, 11:48am CDT | by PR.com

Avail is conducting a 24-week study to evaluate the effect of a once-daily experimental inhalation therapy on arterial stiffness compared to a placebo and another drug in subjects with Chronic Obstructive Pulmonary Disease (COPD).

DeLand, FL, September 29, 2013 --(PR.com)-- To see if you qualify for this COPD Clinical Trial in Florida, visit Avail Clinical Research on the web (http://www.availclinical.com) or contact us directly at (386) 785-2404. There is no cost to participate, no insurance is required, and you may receive compensation for time and travel.

Study Design
This study is designed to evaluate the effect of an experimental inhalation therapy administered once daily via a Novel Dry Powder Inhaler on arterial stiffness compared with placebo and vilanterol over a 24 - week treatment period in subjects with COPD. Vilanterol is included to help explain relative treatment effect of this experimental inhalation therapy in the new combination, however the comparison is not powered. Arterial stiffness will be measured as aPWV. This is a randomised, placebo-controlled, multicenter study. Subjects who meet the eligibility criteria at Screening and meeting the randomisation criteria at the end of a 2-week Run-In period will enter a 24-week treatment period. There will be an approximately 7-day Follow-Up period after the treatment period.

Background & Rationale
Arterial stiffness is increasingly recognized as a surrogate marker for cardiovascular disease (CVD). In particular, arterial stiffness has been shown to be an independent predictor of future fatal and non-fatal CV events and all-cause mortality in hypertensive patients, apparently healthy elderly subjects and a general population. Arterial stiffness can be measured with non-invasive, reproducible and inexpensive techniques, which make it feasible to implement into clinical practice and large-scale clinical studies.

Primary Objectives
The primary objective of the study is to evaluate the effect of an experimental inhalation therapy administered once daily (QD) compared with placebo on aPWV in subjects with COPD and aPWV ≥ 11.0 m/s at baseline.

Inclusion Criteria
1. Type of subject: outpatient
2. Informed consent: Subjects must give their signed and dated written informed consent to participate.
3. Gender: Male or female subjects

A female is eligible to enter and participate in the study if she is of:
-Non-child bearing potential (i.e., physiologically incapable of becoming pregnant, including any female who is post-menopausal or surgically sterile).
-Child bearing potential, has a negative pregnancy test at screening, and agrees to one of the following acceptable contraceptive methods used consistently and correctly:
-- Complete abstinence from intercourse from screening until the Follow-Up Phone Contact; or
-- Male partner is sterile (vasectomy with documentation of azoospermia) prior to female subject entry into the study, and this male partner is the sole partner for that subject; or
-- Implants of levonorgestrel inserted for at least 1 month prior to the study medication administration but not beyond the third successive year following insertion; or
-- Injectable progestogen administered for at least 1 month prior to study medication administration and administered until the Follow-Up Phone Contact; or
-- Oral contraceptive (combined or progestogen only) administered for at least one monthly cycle prior to study medication administration; or
-- Double barrier method: condom and occlusive cap (diaphragm or cervical/vault caps) with spermicidal agent (foam/gel/film/cream/suppository); or
-- An intrauterine device (IUD), inserted by a qualified physician, with published data showing that the highest expected failure rate is less than 1 per year; or
-- Estrogenic vaginal ring; or
-- Percutaneous contraceptive patches

4. Age: ≥40 years of age at Screening (Visit 1)
5. COPD diagnosis: Subjects with a clinical history of COPD
6. Tobacco use: Subjects with a current or prior history of ≥10 pack-years of cigarette smoking at Screening
7. Severity of Disease:

Subjects with a measured post-albuterol/salbutamol FEV1 ≤70% of predicted normal values calculated using NHANES III reference equations at Screening (Visit 1)
Subject with a measured post-albuterol/salbutamol FEV1/FVC ratio of ≤0.70 at Screening (Visit 1)
Post-bronchodilator spirometry will be performed approximately 10-15 minutes after
the subject has self-administered 4 inhalations (i.e., total 400mcg) of albuterol/salbutamol via an MDI with a valved-holding chamber.
8. Baseline aPWV: subjects with a measured aPWV≥11.0 m/s at Screening (Visit 1)

Contact Information:
Avail Clinical Research
Jennifer Economou
(386) 785-2400 336
Contact via Email
www.availclinical.com

Read the full story here: http://www.pr.com/press-release/518663

Press Release Distributed by PR.com

Source: PR.com

 

Don't miss ...

 

blog comments powered by Disqus

Latest stories

WTO fails to reach trade facilitation agreement
Geneva, Aug 2 (IANS) Negotiations at the World Trade Organisation(WTO) has failed to agree on the implementation of the trade facilitation agreement as the deadline of July 31 passed.
 
 
Liberia reports new Ebola cases
Lagos, Aug 1 (IANS) The Liberian government has reported new Ebola cases as of July 28.
 
 
Japanese men's life expectancy over 80 years for first time
Tokyo, Aug 1 (IANS/EFE) The life expectancy of Japanese men stood at 80.21 years in 2013, the first time that men have gone past the 80-year mark in the Asian country, according to the country's ministry of health, labour and welfare.
 
 
Methane created mysterious Siberian crater: Study
London, Aug 1 (IANS) The mysterious crater spotted in the frozen Yamal peninsula in Siberia earlier this month was probably caused by methane released as permafrost thawed, Russian researchers say.
 
 
 

Latest from the Network

Dunga denies Brazil blacklist
Rio de Janeiro, Aug 2 (IANS) Brazil coach Dunga has denied suggestions that striker Fred and goalkeeper Julio Cesar have been placed on a blacklist after the team's ignominious World Cup exit last month. Speaking...
Read more on Sport Balla
 
Lampard set for Manchester City loan
Washington, Aug 2 (IANS) Former Premier League side Chelsea star Frank Lampard will play for Manchester City under a loan deal from his new Major League Soccer Team New York City FC, media reports said. Lampard, who...
Read more on Sport Balla
 
Sarah Hyland to co-host Teen Choice Awards
Sarah Hyland will co-host the Teen Choice Awards later this month. The 'Modern Family' actress, 23, will present the ceremony with 'Teen Wolf' heartthrob Tyler Posey in Los Angeles on August 10. The 22-year-old actor,...
Read more on Celebrity Balla
 
Mandy Moore's home is a zoo
Mandy Moore says her home is turning into a ''little zoo.'' The 30-year-old actress, who is married to musician Ryan Adams, is a huge animal lover and can't stop adopting new pets. The 'Tangled' star told UsMagazine.com...
Read more on Celebrity Balla
 
Brazilian striker Hernane joins Al Nassr
Rio de Janeiro, Aug 2 (IANS) Brazilian forward Hernane has signed a three-year deal with Al Nassr for a reported $7 million. The Saudi Arabian club beat off interest from a number of rival suitors for the Flamengo...
Read more on Sport Balla
 
Emma Watson stands up for Turkish women
Los Angeles, Aug 2 (IANS) "Harry Potter" star Emma Watson has joined a campaign by Turkish women to rebel against a politician who recently branded females "indecent" for laughing in public. Watson is an ambassador...
Read more on Celebrity Balla
 
Tom Cruise surprises at derby event
London, Aug 2 (IANS) Hollywood star Tom Cruise, who is filming the fifth instalment of the "Mission: Impossible" franchise here, surprised revellers at a horse racing event here. He showed up at the event at the...
Read more on Celebrity Balla
 
Sahana finishes eighth in women's high jump
Glasgow, Aug 2 (IANS) Indian athlete Sahana Nagaraj came out with a disappointing performance to finish eighth in the women's high jump final at the Commonwealth Games here Friday. The gold went to Australia's Eleanor...
Read more on Sport Balla
 
Boxers Sarita, Devendro enter final, Pinki wins bronze (Third Lead)
Glasgow, Aug 2 (IANS) Former world champion L. Sarita Devi and her state-mate L. Devendro Singh came out with stupendous performances in their respective bouts to enter the Commonwealth Games boxing finals after Pinki...
Read more on Sport Balla
 
Discus thrower Seema wins silver, Krishna fifth
Glasgow, Aug 2 (IANS) Indian discus thrower Seema Punia won the silver medal with her season's best performance while her compatriot and defending champion Krishna Poonia finished a disappointing fifth at the...
Read more on Sport Balla